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statistically heterogeneous. ConClusions: Medical doctors were more requested 
than dentists and hospitals. The use of health services was more concentrated in 
developed areas. The pooled results of meta-analysis suggest representativeness 
of Brazilian population for the last decade.
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objeCtives: Four hurdles associated with economic evaluations in health care 
interventions were identified and examined in a previous published literature 
review. These hurdles include (i) ‘Ignoring the impact of condition-specific out-
comes’, (ii) ‘Ignoring the impact of QoL externalities’, (iii) ‘Calculation of costs 
from a too narrow perspective’ and (iv) ‘The lack of well-described & standardized 
interventions’. This study aims to determine how healthcare providers experi-
ence and deal with these hurdles in practice and what solutions or new insights 
they would suggest. Methods: Fourteen general practitioners (GPs), who were 
participating in a health care intervention in Flanders, were interviewed about 
the four described hurdles in a semi-structured way. A thematic framework was 
developed to enable the qualitative analysis. Results: The interviews revealed 
a clear need to tackle these hurdles. GPs confirmed that more condition-specific 
outcomes in economic evaluations are needed, especially in the field of mental 
health and stress. The proposed dimensions for the condition-specific question-
naires varied however between the GPs. With respect to QoL externalities, GPs 
confirmed that health care interventions have an impact on the environment of 
the patient (friends and family). There was however no consensus on how this 
impact of QoL externalities should be taken into account. Besides health care 
costs, the impact of health care interventions on work productivity, the patients’ 
social life (culture, sport) and other items such as traffic accidents must be incor-
porated to provide an overall picture. Standardization appears to be of limited 
added value for most of the interviewed GPs because they need a certain degree 
of freedom to interpret the intervention. Lack of time has been claimed by GPs as 
the biggest issue for standardization of health care interventions. ConClusions: 
This qualitative research demonstrated that these hurdles occur in practice and 
contributes to improve the methodological quality of economic evaluations of 
health care interventions.
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objeCtives: Adherence to antidiabetic treatment is a crucial issue in type 2 
diabetes management. Depression negatively influences adherence to self-care 
recommendations, such as diet, physical activity and drug therapy. The objectives 
of this study are to measure the association between depression and discontinu-
ation with antidiabetic drugs (ADs), among new users of oral antidiabetic drugs 
(OADs) and to estimate factors associated with discontinuation among these new 
users with depression. Methods: We used administrative claims data of the 
public health insurance plan in Quebec, Canada, to identify an adult cohort (≥ 18 
years) of new OAD users free of depression between 2000 and 2006. We followed 
patients from OAD initiation up to AD discontinuation, ineligibility to the pub-
lic drug plan, death, or the end of the study, i.e. December 31, 2008, whichever 
came first. A Cox regression model with depression as a time-dependent variable 
was used to compute the adjusted hazard ratio (AHR) of discontinuation. A Cox 
regression models was used to identify factors associated with discontinuation in 
the sub-cohort of patients with depression. Results: We identified 114,366 new 
OAD users, of which 4,808 were diagnosed with depression during follow-up. The 
median time from OAD treatment initiation to discontinuation was 2.4 years: 55.4 
% of patients with depression versus 44.5% without depression discontinued their 
treatment during follow-up. The AHR of discontinuation with ADs was 1.52 (95% 
confidence interval [CI]: 1.41-1.63). Among the 4,808 patients with depression, 
independent factors associated with discontinuation included starting treatment 
with other drugs than metformin (especially polytherapy with insulin), being pre-
scribed the first OAD by a specialist (vs a general practitioner), and younger age 
at OAD initiation (< 45 years). ConClusions: Patients with depression are more 
likely to discontinue their treatment. Physicians should target patients at risk 
for discontinuation in order to improve persistence with antidiabetic drugs and 
diabetes management.
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objeCtives: With the ageing of the Singapore population, the incidence of falls 
and its consequences will increase unless effective interventions are implemented. 
This evaluation assesses the effectiveness of the Stepping Out program in pre-
venting falls, improving overall physical performance, general well-being and falls 
efficacy. Methods: Stepping Out is a 52-week program for community-dwelling 
elderly residents. Participants were risk-stratified prior to receiving physical exer-
cises, education, and referrals to healthcare providers and community partners. 
The first 3-months were supervised by nurses and physiotherapists, and the next 
9-months by community volunteers. The evaluation utilized a prospective cohort 
design with waitlisted controls. Eligible participants were invited into the program 
one year before receiving the intervention, during which data collected for that 
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objeCtives: This study aimed to provide insight into the current and potential use 
of economic evaluations in Dutch healthcare decision-making and to identify bar-
riers and facilitators to the use of such studies. Methods: Interviews containing 
semi-structured and structured questions were conducted among Dutch healthcare 
decision-makers. Responses to the semi-structured questions were analyzed using a 
constant comparative approach. For the responses to the structured questions, sum-
mary statistics were prepared. Results: Sixteen healthcare decision-makers from 
the macro- (national), meso- (local/regional), and micro-level (patient setting) were 
interviewed as well as two health economic experts. Decision-makers’ knowledge of 
economic evaluations was only modest, and their current use appeared to be limited. 
Nonetheless, decision-makers recognized the importance of economic evaluations 
and saw several opportunities for extending their use at the macro- and meso-level, 
but not at the micro-level. The disparity between the limited use and recognition of 
the importance of economic evaluations is likely due to the many barriers decision-
makers experience preventing their use. Such barriers include a lack of resources, 
methodological factors, lack of consensus-based willingness-to-pay thresholds, lack 
of relevant economic evaluations, public resistance, incentives to treat, ambiguity 
about the physicians’ responsibility for improving the efficiency of healthcare, and a 
limited ability to shift resources between sectors. Possible facilitators for extending 
the use of economic evaluations include educating decision-makers and the general 
population about economic evaluations, presenting economic evaluation results in 
a clearer and more understandable way, providing incentives for using economic 
evaluations, and improving the reliability, consistency, and transparency of eco-
nomic evaluations. ConClusions: This study demonstrated that the current use 
and impact of economic evaluations in Dutch healthcare decision-making is limited 
at best. Therefore, strategies are needed to overcome the barriers that currently pre-
vent economic evaluations from being used extensively, and recommendations will 
be provided as to what those strategies could be.
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objeCtives: The aim of this work is to evaluate the success rate of including 
medicinal products to the reimbursement system after the adoption of new drug 
legislation in December 2011. Methods: We assessed the inclusion of drugs to 
the reimbursement system based on data published on the Ministry of Health web-
site. We evaluated the success rate of reimbursement applications in the period 
from 1.1.2012 to 30.6.2015. We analysed separately the successful and unsuccess-
ful proceedings, the success rate of proceedings in individual therapeutic groups, 
as well as the development of the success rate of the inclusion of drugs over the 
monitored period. With unsuccessful proceedings, we assessed the shortcomings 
in pharmacoeconomic analyses given in the decisions. Results: In the evaluated 
period a total of 178 applications were registered for the inclusion of new drugs 
to the reimbursement system. Of these, 55 cases (30.9%) concerned drugs that in 
the Budget impact analysis showed the need for an increase in expenditure. In 79 
cases, a new active substance was included, with the remainder comprising fixed 
combinations, new strengths, forms and packaging. A total of 127 applications were 
successful (71.35%). In the case of applications with an budget impact, the success 
rate was 60%. In the case of unsuccessful submissions, in 58.8% the reason for non-
inclusion was the pharmacoeconomic analysis and the most common shortcomings 
concerned the selection of analysis (13.7%), selection of comparator (11.8%) and 
incorrect calculation of output parameters (11.8%). The highest inclusion success 
rate was seen for drugs in the ATC groups M, V and D, while the lowest was for drugs 
in groups H, L and S. ConClusions: The success rate for inclusion of new drugs is 
relatively high in Slovakia, but the majority of included drugs do not require higher 
healthcare expenditures. The most frequent reason for non-inclusion of a drug was 
shortcomings in the pharmacoeconomic analysis.
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objeCtives: To estimate the prevalence of health services use in Brazil. Methods: 
The protocol of present review is available at PROSPERO (CRD42015016648). A struc-
tured search for population-based surveys was performed in MEDLINE, EMBASE, 
Scopus, LILACS, SciELO and Brazilian theses repository. Selection of studies, data 
extraction and critical appraisal processes was completed by two independent 
reviewers. Methodological quality assessment included random sample, unbi-
ased sampling frame, sample size, standard for measures, unbiased assessors for 
outcomes, response rate, subgroup analysis and description of subjects. In STATA, 
results of similar studies were grouped in meta-analysis of random effects and 
their heterogeneity was investigated by a model of inverse variance. All results 
were stratified by recall period and health service (dental or medical consultation 
or hospitalization). Results: The search recovered 1,312 references. Fifteen articles 
and five national surveys were included. The studies presented good methodological 
quality. They were made between 1995-2015 and, mainly, in the southern region. 
829,941 people were interviewed about the use of dental services in the past 360 
days, of which 32% (95% CI 22.7-41.9%) responded positively. 70% (95% CI 64.9-75.1%) 
of 710,703 subjects visited a doctor in last 54 weeks. Finally, 10.4% (95% CI 9.5-11.3%) 
of 695,072 respondents report hospitalization in previous 12 months. All results were 
